FMC Stock FMC Corporation
US · NYSELast in our picks 2026-10-23 — not in the current list; analysis below is from that screen
Crop-protection inventory normalization and cost controls offer recovery potential after prolonged weakness.
Future value: $9.18 (+82.87%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Channel destocking appears to be easing, creating a potential earnings inflection.
- ▾Below 50-day MA (-48.64%)
- ▸Volume 1.55× average — accumulation
- ▾Near 52-week low (0.8% of range)
- ▸~83% upside to price target
Is FMC a buy right now?
Trend: FMC is trading below the 50-day average (-47.78%), RSI 45 — neutral momentum, with a 3-month return of -54.59%.
Valuation & quality: FMC Corporation trades on forward P/E 3.3, PEG 1.55, price-to-book 0.35; fundamentals show net margin -84.8%, return on equity -88.4%, revenue growth -17.5% year on year.
Analyst consensus: 15 analysts have a mean 12-month price target of $8.71 (+89% vs the last close; range $4.00 – $18.00), consensus rating “hold”.
Income: trailing dividend yield 6.34%.
Our screen: BUY (score 2) — Crop-protection inventory normalization and cost controls offer recovery potential after prolonged weakness.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +16.80% | -10.70% | -11.20% | -15.80% | -6.90% | +7.70% | -22.60% | -43.40% |
Fundamentals
Analyst price target
Technical signals
About FMC Corporation
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides.
Sector: Basic Materials · Industry: Agricultural Inputs · United States · 5,500 employees · Website
Related Materials picks
Browse: all US stocks · Materials picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.